Follow
Chrysanthi Sardeli, Associate Professor of Pharmacology-Clinical Pharmacology
Chrysanthi Sardeli, Associate Professor of Pharmacology-Clinical Pharmacology
Verified email at auth.gr
Title
Cited by
Cited by
Year
Compliance and viewpoint of glaucoma patients in Greece
AGP Konstas, G Maskaleris, S Gratsonidis, C Sardelli
Eye 14 (5), 752-756, 2000
2212000
Effect of early compared with delayed enteral nutrition on endocrine function in patients with traumatic brain injury: an open‐labeled randomized trial
M Chourdakis, MM Kraus, T Tzellos, C Sardeli, M Peftoulidou, ...
Journal of Parenteral and Enteral Nutrition 36 (1), 108-116, 2012
1502012
Efficacy, safety and tolerability of green tea catechins in the treatment of external anogenital warts: a systematic review and meta‐analysis
TG Tzellos, C Sardeli, A Lallas, G Papazisis, M Chourdakis, D Kouvelas
Journal of the European Academy of Dermatology and Venereology 25 (3), 345-353, 2011
892011
PDE5 inhibitors: in vitro and in vivo pharmacological profile
D Kouvelas, A Goulas, G Papazisis, C Sardeli, C Pourzitaki
Current pharmaceutical design 15 (30), 3464-3475, 2009
792009
Epidemiology of antenatal depression among women with high-risk pregnancies due to obstetric complications: a scoping review
I Tsakiridis, V Bousi, T Dagklis, C Sardeli, V Nikolopoulou, G Papazisis
Archives of gynecology and obstetrics 300, 849-859, 2019
762019
Deferoxamine decreases the excitatory amino acid levels and improves the histological outcome in the hippocampus of neonatal rats after hypoxia–ischemia
G Papazisis, C Pourzitaki, C Sardeli, A Lallas, E Amaniti, D Kouvelas
Pharmacological Research 57 (1), 73-78, 2008
722008
A2δ ligands gabapentin and pregabalin: future implications in daily clinical practice
DK TG Tzellos, G Papazisis, KA Toulis, Ch Sardeli
Hippokratia 14 (2), 71, 2010
482010
The role of sarcosine, uracil, and kynurenic acid metabolism in urine for diagnosis and progression monitoring of prostate cancer
G Gkotsos, C Virgiliou, I Lagoudaki, C Sardeli, N Raikos, G Theodoridis, ...
Metabolites 7 (1), 9, 2017
422017
Pregabalin abuse after past substance-seeking behavior.
G Papazisis, G Garyfallos, C Sardeli, D Kouvelas
International journal of clinical pharmacology and therapeutics 51 (5), 441-442, 2013
392013
Possible adverse effects of immunotherapy in non-small cell lung cancer; treatment and follow-up of three cases
P Zarogoulidis, P Chinelis, A Athanasiadou, T Tsiouda, G Trakada, ...
Respiratory medicine case reports 22, 101-105, 2017
332017
α-MSH prevents impairment in renal function and dysregulation of AQPs and Na-K-ATPase in rats with bilateral ureteral obstruction
C Li, Y Shi, W Wang, C Sardeli, TH Kwon, K Thomsen, T Jonassen, ...
American Journal of Physiology-Renal Physiology 290 (2), F384-F396, 2006
282006
Antidepressants on multiple sclerosis: a review of in vitro and in vivo models
E Stamoula, S Siafis, I Dardalas, A Ainatzoglou, A Matsas, T Athanasiadis, ...
Frontiers in Immunology 12, 677879, 2021
272021
Outcome of site-specific fascia repair for rectocele
C Sardeli, SM Axelsen, D Kjær, KM Bek
Acta obstetricia et gynecologica Scandinavica 86 (8), 973-977, 2007
262007
Use of porcine small intestinal submucosa in the surgical treatment of recurrent rectocele in a patient with Ehlers–Danlos syndrome type III
C Sardeli, SM Axelsen, KM Bek
International Urogynecology Journal 16, 504-505, 2005
252005
Pharmacologic and non-pharmacologic interventions for HIV-neuropathy pain. A systematic review and a meta-analysis
A Amaniti, C Sardeli, V Fyntanidou, P Papakonstantinou, I Dalakakis, ...
Medicina 55 (12), 762, 2019
242019
Inhaled cisplatin for NSCLC: facts and results
C Kosmidis, K Sapalidis, P Zarogoulidis, C Sardeli, C Koulouris, ...
International Journal of Molecular Sciences 20 (8), 2005, 2019
212019
Sex differences and adverse effects between chemotherapy and immunotherapy for non-small cell lung cancer
T Tsiouda, C Sardeli, K Porpodis, M Pilikidou, G Apostolidis, K Kyrka, ...
Journal of Cancer 11 (11), 3407, 2020
172020
Inhaled chemotherapy adverse effects: mechanisms and protection methods
C Sardeli, P Zarogoulidis, C Kosmidis, A Amaniti, A Katsaounis, ...
Lung Cancer Management 8 (4), LMT19, 2019
172019
EBUS-TNBA 22G samples: Comparison of PD-L1 expression between DAKO and BIOCARE®
K Sapalidis, P Zarogoulidis, D Petridis, C Kosmidis, B Fyntanidou, ...
Journal of Cancer 10 (20), 4739, 2019
172019
Nivolumab as first-line treatment in non-small cell lung cancer patients—key factors: tumor mutation burden and PD-L1≥ 50%
P Zarogoulidis, V Papadopoulos, E Maragouli, G Papatsibas, C Sardeli, ...
Translational Lung Cancer Research 7 (Suppl 1), S28, 2018
172018
The system can't perform the operation now. Try again later.
Articles 1–20